Conclusion: Several inhaled insulin products are under development ... particularly oral and nasal formulations, have not been successful. The major problem with these approaches has been biology ...

Scientists have developed a once-a-day nasal gel formulation for the delivery of insulin that could put an end to injections for Type 1 diabetes sufferers. In results published today in the Royal ...

Inhaler: peak plasma ... Nasal Spray antagonized by nasal vasoconstrictors (eg, xylometazoline). Smoking cessation potentiates theophylline, insulin, β-blockers, pentazocine, oxazepam, tricyclic ...

Shares of MannKind Corporation climbed more than 2% in premarket trading Wednesday, on track to extend gains from the ...

Results of phase I study of Baxter Healthcare Corporation’s pulmonary insulin produced with Baxter's Promaxx microsphere technology and administered using a small, standard dry powder inhaler ...

The Ministry of Health (MoH) has approved the registration of an insulin inhalation dry powder, widely seen as a revolution in diabetes medication. “Exubera, the first inhaled form of insulin ...

But biotech and pharma companies are now working on simpler treatments that people could take as pills, nasal sprays, or inhalers. An antiviral drug from Merck and Ridgeback Biotherapeutics is on ...

India has the 2nd highest burden of diabetes worldwideCDSCO decision follows existing approvals in the U.S.A. and BrazilMannKind expects to ship ...

A curious link between Alzheimer's and insulin resistance is now so well-established, the neurodegenerative disease is sometimes called type III diabetes. Now a nasal spray developed by Italian ...